| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 621 | 2017 |
| The use of vancomycin with its therapeutic and adverse effects: a review. FR Bruniera, FM Ferreira, LRM Saviolli, MR Bacci, D Feder, M Pedreira, ... European Review for Medical & Pharmacological Sciences 19 (4), 2015 | 335 | 2015 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 202 | 2019 |
| A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy N Goemans, E Mercuri, E Belousova, H Komaki, A Dubrovsky, ... Neuromuscular Disorders 28 (1), 4-15, 2018 | 128 | 2018 |
| IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients MR Bacci, RCP Leme, NPC Zing, N Murad, F Adami, PF Hinnig, D Feder, ... Brazilian Journal of Medical and Biological Research 48 (5), 427-432, 2015 | 119 | 2015 |
| The Role of Vitamin D in Pathophysiology and Treatment of Fibromyalgia. CAS ESUS, D Feder, MFP PERES Current Pain and Headache Reports 17, 355, 2013 | 78 | 2013 |
| Analysis of the relationship between type II diabetes mellitus and Parkinson’s disease: a systematic review F Camargo Maluf, D Feder, A Alves de Siqueira Carvalho Parkinson’s Disease 2019 (1), 4951379, 2019 | 65 | 2019 |
| Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus. R FA, C FB, S JH, D Toni VF, M VH, F D. Eur Rev Med Pharmacol Sci. 21 (1), 199-211, 2017 | 64 | 2017 |
| Warfarin: pharmacological profile and drug interactions with antidepressants JS TELES, EY FUKUDA, D Feder Einstein (São Paulo) 10, 110-115, 2012 | 55 | 2012 |
| Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD Dogs KPC ARAUJO, G BONUCCELLI, CN DUARTE, TP GAIAD, DF MOREIRA, ... Plos One 8, e61367, 2013 | 53 | 2013 |
| The use of drugs in patients who have undergone bariatric surgery MSP Geraldo, FLA FONSECA, MRF Veiga, D FEDER International Journal of General Medicine 7, 219-224, 2014 | 44 | 2014 |
| ‘Minimal symptom expression’in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab J Vissing, S Jacob, KP Fujita, F O’Brien, JF Howard Journal of neurology 267 (7), 1991-2001, 2020 | 40 | 2020 |
| Hematological and hepatic effects of vascular epidermal growth factor (VEGF) used to stimulate hair growth in an animal model LA Gnann, RF Castro, LA Azzalis, D Feder, FF Perazzo, EC Pereira, ... BMC dermatology 13, 1-5, 2013 | 40 | 2013 |
| Esclerose múltipla: revisão dos principais tratamentos da doença B Alves, R Angeloni, L Azzalis, E Pereira, F Perazzo, PC Rosa, D Feder, ... Saúde e meio ambiente: Revista interdisciplinar 3 (2), 19-34, 2014 | 34 | 2014 |
| Varfarina: perfil farmacológico e interações medicamentosas com antidepressivos JS Teles, EY Fukuda, D Feder einstein (São Paulo) 10, 110-115, 2012 | 29 | 2012 |
| Consistent improvement with eculizumab across muscle groups in myasthenia gravis R Mantegazza, FL O'Brien, M Yountz, JF Howard Jr, REGAIN Study Group, ... Annals of clinical and translational neurology 7 (8), 1327-1339, 2020 | 24 | 2020 |
| Cytotoxic, hematologic and histologic effects of niobium pentoxide in Swiss mice NA DSOUKI, MP LIMA, R CORAZZINI, TM GÁSCON, LA AZZALIS, ... Journal of Materials Science. Materials in Medicine 1, 22, 2014 | 24 | 2014 |
| Assessing the metabolic impact of ground chia seed in overweight and obese prepubescent children: results of a double-blind randomized clinical trial CS da Silva, CRA Monteiro, GHF da Silva, ROS Sarni, FIS Souza, ... Journal of medicinal food 23 (3), 224-232, 2020 | 20 | 2020 |
| Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study H Murai, A Uzawa, Y Suzuki, T Imai, H Shiraishi, H Suzuki, M Okumura, ... Journal of the neurological sciences 407, 116419, 2019 | 20 | 2019 |
| The effects of transcutaneous low-level laser therapy on the skin healing process: an experimental model FS Ramos, LBM Maifrino, S Alves, B da Costa Aguiar Alves, MM Perez, ... Lasers in Medical Science 33, 967-976, 2018 | 20 | 2018 |
